|
Ding WY, Rivera-Caravaca JM, Shantsila A, Marin F, Gupta D, Roldan V, Lip GYH. Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'. Int J Clin Pract. 2021 Apr;75(4):e13888. doi: 10.1111/ijcp.13888. Epub 2020 Dec 15. PubMed PMID: 33283377.
AÑO: 2021; IF: 3.149
|
33283377
|
Rivera-Caravaca JM, Buckley BJR, Harrison SL, Fazio-Eynullayeva E, Underhill P, Marin F, Lip GYH. Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes. Thromb Res. 2021 Sep;205:1-7. doi: 10.1016/j.thromres.2021.06.014. Epub 2021 Jun 27. PubMed PMID: 34218058; PubMed Central PMCID: PMC8236305.
AÑO: 2021; IF: 10.407
|
|
Diez-Villanueva P, Garcia-Acuna JM, Raposeiras-Roubin S, Barrabes JA, Cordero A, Martinez-Selles M, Bardaji A, Marin F, Ruiz-Nodar JM, Vicente-Ibarra N, Alonso Salinas GL, Cid-Alvarez B, Abu Assi E, Formiga F, Nunez J, Nunez E, Ariza-Sole A, Sanchis J. Prognosis Impact of Diabetes in Elderly Women and Men with Non-ST Elevation Acute Coronary Syndrome. J Clin Med. 2021 Sep 26;10(19):4403. doi: 10.3390/jcm10194403. PubMed PMID: 34640420; PubMed Central PMCID: PMC8509190.
AÑO: 2021; IF: 4.964
|
|
Proietti M, Vitolo M, Harrison SL, Lane DA, Fauchier L, Marin F, Nabauer M, Potpara TS, Dan GA, Boriani G, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry. BMC Med. 2021 Oct 20;19(1):256. doi: 10.1186/s12916-021-02120-3. PubMed PMID: 34666757; PubMed Central PMCID: PMC8527730.
AÑO: 2021; IF: 11.15
|
|
Van Mieghem NM, Unverdorben M, Hengstenberg C, Mollmann H, Mehran R, Lopez-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodes-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. PubMed PMID: 34449183.
AÑO: 2021; IF: 176.079
|